Navigation Links
Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
Date:1/3/2008

ment option for patients with type 2 diabetes and the healthcare providers who treat them."

GLP-1 and GIP are produced by the digestive tract in response to food, and regulate glucose balance, primarily by stimulating glucose-dependent insulin secretion. In addition, GLP-1 suppresses pancreatic glucagon secretion and subsequent liver glucose production, enhances glucose disposal, slows gastric emptying, and elicits satiety, a feeling of fullness.

About Type 2 Diabetes

Type 2 diabetes has reached epidemic proportions in the United States with almost 20 million people currently living with the disease. A progressive disease, type 2 diabetes requires continued monitoring by a physician and patients are often required to take multiple medications at any time-in addition to diet and exercise-in order to maintain glucose control. There are two primary defects associated with type 2 diabetes: the body does not efficiently use the insulin it produces -- insulin resistance -- and/or it does not produce enough insulin-insulin deficiency. DPP-4 inhibitors offer a new way to treat insulin deficiency and have the potential to improve pancreatic beta-cell function.

About Takeda's Commitment to Type 2 Diabetes

Takeda has a long-standing tradition of striving toward better health for people living with type 2 diabetes by developing innovative pharmaceutical solutions to help manage their condition. In 1999, Takeda launched ACTOS(R) (pioglitazone HCl) -- an insulin sensitizer which today is available globally -- followed in recent years by the introduction of the ACTOS family of products, with more than 75 million prescriptions written, covering more than 8.5 million patients and 4.5 million patient years.

Over the past decade, Takeda has furthered their commitment to people living with type 2 diabetes and pursued the development of alogliptin, an investigational DPP-4 inhibitor. ACTOS and alogliptin have distinct but complementary mechanism
'/>"/>

SOURCE Takeda Global Research & Development Center, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
3. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
4. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
5. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
6. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
7. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
8. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
9. Indevus Announces Submission of New Drug Application
10. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
11. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p02316671/Global-Orthopedic-Soft-Tissue-Repair-Devices-Market-2014-2018.html ... soft tissues are the mass of cells that ... types of orthopedic soft tissues such as tendons, ...
(Date:8/27/2014)... 2014 Decision Resources Group finds that the ... Memphis health system and hospital sector in ... rivals Methodist Le Bonheur Healthcare and Baptist Memorial Health ... patient care. In addition, a national contract recently signed ... plan enrollment in the Memphis ...
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p02316644/Global-Heart-Valve-Repair-and-Replacement-Market-2014-2018.html ... are structures in the human heart which control ... A person affected with heart valve diseases such ...
Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Memphis-area Health Systems Turn Attention to Clinical Integration 2Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4
... , PITTSBURGH, Dec. 22 Mylan Inc. (Nasdaq: MYL ... received tentative approval from the U.S. Food and Drug Administration ... for its New Drug Application (NDA) for Efavirenz Tablets, 50 ... in tablet form were developed by Matrix for use in ...
... , , , , , , CAPUA, Italy, Dec. 22 ... an agreement with Laboratoires Mayoly Spindler, Chatou Cedex, France, for ... process development and commenced cGMP manufacture of the Mayoly Spindler ... BioSolutions manufactures the lipase compound at its microbial fermentation facility ...
Cached Medicine Technology:Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets 2DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 2DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 3DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 4
(Date:8/27/2014)... The National League for Nursing is ... RN, FAAN, became the inaugural director of the ... the Science of Nursing Education , effective August 11. ... NLN Home for Transformative Excellence, established with the League’s ... , Under Dr. Dennis’s leadership, the NLN/Chamberlain Center ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Delta, a ... recently added several practical Cat D7R Dozers to its ... company’s senior spokesman has announced that all these items ... this promotion is to expand Delta’s market share in ... proud to launch the special offer; he has much ...
(Date:8/27/2014)... Lake Worth, FL (PRWEB) August 27, 2014 ... they are now a sponsor for Florida Mental Health ... to the benefits the new sponsorship is sure to ... meeting the professional needs of Florida’s licensed mental health ... division of the American Counseling Association (ACA) and since ...
(Date:8/27/2014)... August 27, 2014 The New York ... is holding free events about “ Sexuality & Intimacy ... Treston. These straightforward and entertaining discussions are for mature ... Mobility (501 Concord Avenue, Mamaroneck, NY) and October 7 ... Bethpage, NY). , The New York Mobility Club ...
(Date:8/27/2014)... The American College of ... management and treatment of pulmonary arterial hypertension (PAH) ... in Adults: CHEST Guideline, in the journal CHEST. ... and provide the latest and most accurate treatment ... Association (PHA) – the country’s leading pulmonary ...
Breaking Medicine News(10 mins):Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Millennium Treatment Group Sponsors Florida Mental Health Counselors Association 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2
... Spain throughout the second half of the twentieth century. ... factors such as the advice of healthcare professionals, longer ... her level of education. "Up until not ... but things have changed in the second half of ...
... HealthDay Reporter , THURSDAY, Sept. 29 (HealthDay News) -- ... the globe, new research suggests that folks seem to awaken ... regardless of where they live. The novel study by ... people in 84 countries over two years, finding that work, ...
... IL Ben Franklin was right, at least on the healthy ... helped a cross-section of early-bird Australian youths keep slimmer and more ... the same amount of sleep. A study in the Oct. ... and wake times of 2,200 Australian participants, ages 9 to 16, ...
... , THURSDAY, Sept. 29 (HealthDay News) --,New genes associated ... large-scale analysis of genetic data related to the disease. ... six large databases for DNA data from about 10,000 ... In addition to validating results from previous research, ...
... has received a $750,000 grant from the Cleveland Foundation ... Stanley Hazen, M.D., Ph.D., will be ... spans a broad range of topics, from researching the ... identifying non-invasive testing for asthma. Recently, he published a ...
... in normal tissue may play a different role in colon ... researchers at the University of Illinois at Chicago College of ... skin and gut cells -- and in cancerous, but not ... the normal function of this protein in the gut, where ...
Cached Medicine News:Health News:Woman with a higher social standing and educational attainment breastfeed for longer 2Health News:Twitter Reflects World's Changing Moods 2Health News:Twitter Reflects World's Changing Moods 3Health News:Early to bed and early to rise -- study suggests it's keeping kids leaner 2Health News:Knockout of protein prevents colon tumor formation in mice 2
Ammonia reagent is used for the quantitative and enzymatic determination of ammonia in human plasma....
The Proteineer suite integrates powerful mass spectrometers with robotics and bioinformatics to deliver maximum productivity in high-throughput proteomics....
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
... functions over a wide range of ... delivering more thorough characterization than other ... the relative change in the distribution ... way to measure heterogeneity, stoichiometry and ...
Medicine Products: